Antioxidants: powering the fight against fetal hypoxia
Open Access
- 21 August 2025
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 380 (1933) , 20240183
Abstract
Hypoxia is a common challenge in fetal development. Short-term acute episodes occur during labour owing to uterine contractions or umbilical cord compression. In response, the fetus prioritizes oxygen and nutrient delivery to the brain, heart and adrenal glands at the expense of other organs, a mechanism known as the fetal brain-sparing response. However, prolonged fetal hypoxia can occur in many conditions, including placental insufficiency, pre-eclampsia, high-altitude pregnancy and fetal congenital heart disease. Chronic hypoxia increases placental and fetal oxidative stress, triggering increased long-term cardiovascular risks in adult offspring, including hypertension and coronary artery disease. Antioxidants could potentially prevent this. However, as reactive oxygen species play a crucial role in the fetal brain-sparing response, excessive antioxidant use could weaken fetal defences against acute hypoxia, increasing the risk of hypoxic–ischaemic encephalopathy. Thus, for clinical use, an antioxidant should protect against programmed cardiovascular disease while preserving fetal brain sparing. This review summarizes preclinical evidence on the efficacy of antioxidants in preventing cardiovascular disease in the offspring of hypoxic pregnancy. We compare their effects on fetal brain sparing, highlighting the ability of the mitochondria-targeted antioxidant MitoQ to protect against programmed cardiovascular disease while preserving fetal brain sparing and outlining steps for clinical translation. This article is part of the discussion meeting issue ‘Pregnancy at high altitude: the challenge of hypoxia’.Keywords
This publication has 132 references indexed in Scilit:
- Fine‐tuning the hydrophobicity of a mitochondria‐targeted antioxidantFEBS Letters, 2004
- Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implicationsThe Journal of Physiology, 2004
- Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. III. Changes in Complicated PregnanciesPlacenta, 2004
- Targeting Coenzyme Q Derivatives to Mitochondria2004
- Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonistsCurrent Urology Reports, 2003
- Enhanced nitric oxide activity offsets peripheral vasoconstriction during acute hypoxaemia via chemoreflex and adrenomedullary actions in the sheep fetusThe Journal of Physiology, 2003
- Selective Targeting of a Redox-active Ubiquinone to Mitochondria within CellsJournal of Biological Chemistry, 2001
- Ascorbate Prevents the Interaction of Superoxide and Nitric Oxide Only at Very High Physiological ConcentrationsCirculation Research, 1998
- Mechanisms of hypoxic cerebral vasodilatationPharmacology & Therapeutics, 1995
- Afferent and efferent components of the cardiovascular reflex responses to acute hypoxia in term fetal sheep.The Journal of Physiology, 1993